EUVIMEDEUVIMED entdecken
Crossref

Less is More: Biomimetic Hybrid Membrane Nanocarriers for Highly Efficient Tumor Targeted Drug Delivery

Siwen Chen, Haibo Lan, Minyi Liu, Chenxi He, Qiuyu Li, Shuting Zheng, Yinfei Zheng, Zede Wu, Tiancai Liu, Bingxia Zhao iD

Small · 2025

DOI: 10.1002/smll.202407245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, 2025. Verfasst von Siwen Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guan…. Hauptthemen laut MEDLINE: Nanoparticles, Drug Delivery Systems, Biomimetic Materials, Drug Carriers. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biomimetic camouflaged nanocarriers coated with cancer cell membranes (CCMs) have attracted considerable research attention for drug delivery application. CCM‐camouflaged nanocarriers have inherent tumor‐homologous targeting ability. However, they enter cancer cells via endocytosis, which is not efficient for drug delivery. Switching the internalization mechanism to membrane fusion may enhance their delivery efficiency. In this study, an innovative biomimetic‐targeting nanocarrier is designed by hybridizing CCMs with pH‐sensitive liposomes (1,2‐dioleoyl‐sn‐glycero‐3‐phosphoethanolamine liposomes, DOPE‐Lipo), named as CCMpHD. The presence of CCMs makes the nanocarriers capable of homologous targeting, and the DOPE‐Lipo hybrid allows the nanocarriers to achieve efficient internalization via membrane fusion. Notably, the cellular uptake of CCMpHD is significantly higher than that of the CCMs. The most efficient delivery is achieved with 1/10 CCMs, which requires remarkably less cell membranes. Doxorubicin (DOX) is used as a model drug to characterize the homologous targeting drug delivery properties of the hybrid nanocarriers. Both in vitro and in vivo experiments demonstrated that the nanocarriers exhibited satisfactory biosafety and enhanced tumor‐targeted delivery. With enhanced delivery efficiency whilst requiring fewer CCMs, these hybrid membrane nanocarriers provides a new strategy for CCM‐based drug delivery in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesDrug Delivery SystemsBiomimetic MaterialsDrug CarriersBiomimeticsNeoplasmsHumansDoxorubicinAnimalsLiposomesCell MembraneCell Line, TumorMicePhosphatidylethanolamines

Stichwörter der Autor:innen

biomimetic nanocarriercancer cell membranemembrane fusiontargeted drug delivery

Substanzen

DoxorubicinLiposomesDrug CarriersPhosphatidylethanolamines

Autor:innen und Institutionen

  • Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, P. R. China.
  • Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, P. R. China.
  • Key Laboratory of Antibody Engineering of Guangdong Higher Education Institutes, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, 510515, P. R. China.
  • Experimental Education/Administration Center, School of Basic Medical Science, Southern Medical University, Guangzhou, 510515, P. R. China.

ORCID-Profile: Bingxia Zhao

Förderung

  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Chen, S., Lan, H., Liu, M., He, C., Li, Q., Zheng, S., Zheng, Y., Wu, Z., Liu, T., & Zhao, B. (2025). Less is More: Biomimetic Hybrid Membrane Nanocarriers for Highly Efficient Tumor Targeted Drug Delivery. Small. https://doi.org/10.1002/smll.202407245

Vancouver

Chen S, Lan H, Liu M, He C, Li Q, Zheng S, et al. Less is More: Biomimetic Hybrid Membrane Nanocarriers for Highly Efficient Tumor Targeted Drug Delivery. Small. 2025. doi:10.1002/smll.202407245

BibTeX
@article{Chen2025,
  author = {Chen, Siwen and Lan, Haibo and Liu, Minyi and He, Chenxi and Li, Qiuyu and Zheng, Shuting and Zheng, Yinfei and Wu, Zede and Liu, Tiancai and Zhao, Bingxia},
  title = {Less is More: Biomimetic Hybrid Membrane Nanocarriers for Highly Efficient Tumor Targeted Drug Delivery},
  journal = {Small},
  year = {2025},
  doi = {10.1002/smll.202407245}
}
Kostenlos starten →